Home » Healthcare » Cannabinoid Biosynthesis Market

Cannabinoid Biosynthesis Market By Application (Anxiety and Pain Management, Nausea Treatment, Appetite Stimulation)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

The global cannabinoid biosynthesis market is segmented by type, application, and region. The CBD type segment is the most popular, with THC segments holding the highest CAGR over the forecast period. Anxiety and pain management holds the largest market share for the application segment, with Asia Pacific leading the market growth.

The global cannabinoid biosynthesis market has been driven by growing medical applications of cannabinoids driving the market growth over the forecast period. Additionally, a rise in awareness about the benefit of cannabis in medical use globally is also driving market growth. However, the market also faces significant challenges, including Stringent government regulations for cannabis use and application.

Nonetheless, the global cannabinoid biosynthesis market offers significant growth opportunities, such as growing cases of multiple sclerosis. Additionally, the demand for Cannabinoid Biosynthesis will be driven by expanding awareness campaigns and initiatives by public and private organizations about sex education and related sexual health items.

Market Overview

The global cannabinoid biosynthesis market has experienced consistent growth in recent years and is projected to maintain a compound annual growth rate (CAGR) of 16.50% from 2023 to 2030. In 2022, the market was valued at USD 16.2 billion, and it is anticipated to reach USD 47.18 billion by 2030.

What Are the Main Drivers of The Global Cannabinoid Biosynthesis Market?

Several factors, including the growing medical applications of cannabinoids, drive the global cannabinoid biosynthesis market.

What Are the Major Challenges Faced by The Global Cannabinoid Biosynthesis Market?

The global cannabinoid biosynthesis market also faces several challenges, including stringent government regulations for cannabis use and application.

What Are the Growth Opportunities in The Global Cannabinoid Biosynthesis Market?

The global cannabinoid biosynthesis market offers significant growth opportunities, such as growing cases of multiple sclerosis.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Executive Summary

Overview of the Global Cannabinoid Biosynthesis Market

The global cannabinoid biosynthesis market has witnessed steady growth driven by advancements in cannabis biosynthesis technology. This innovative technology has become a game-changer in the life sciences industry, providing a range of advantages for both life sciences companies and licensed producers (LPs). By utilizing cannabinoid biosynthesis, these entities can benefit from cost-effectiveness and the potential to improve the quality of their cannabis products.

Market Definition

The global cannabinoid biosynthesis market is experiencing significant growth and is poised for further expansion in the coming years. Cannabinoid biosynthesis refers to the engineering microorganisms to produce cannabinoids, the active compounds found in cannabis plants, in a controlled laboratory setting. This innovative technology offers numerous advantages over traditional cultivation methods, including scalability, consistency, and cost-effectiveness. As a result, it has garnered immense interest from researchers, pharmaceutical companies, and investors, driving the growth of the global cannabinoid biosynthesis market.

Market Insights

The global demand for cannabinoid biosynthesis is accounted for USD 16.2 Billion in 2022 and it is expected to grow to USD 47.18 Billion in 2030, growing at a CAGR of 16.50% between 2023 and 2030.
CBD cannabinoid biosynthesis is the leading segment and held around half the share in value in 2022.
THC cannabinoid biosynthesis hold exhibit the fastest CAGR during the forecast period.
Anxiety and pain management platform is expected to post the highest market share in 2022
Nausea treatment holds the leading market share, with more than 45% share in 2022.
North America is fuelling the growth of the cannabinoid biosynthesis industry with a nearly two-fifth share in 2022, while Europe and Asia Pacific collectively accounted for just under 55% share in 2022. North America held over 22% share in 2022.
The legalization and decriminalization of cannabis in several countries have opened up opportunities for the medical and recreational use of cannabinoids. With changing regulatory frameworks, there is a growing need for a standardized and regulated supply of cannabinoids.
Biosynthesis technology enables the production of cannabinoids without relying on traditional cultivation methods, providing a controlled and reliable source of these compounds. This aspect of biosynthesis is particularly appealing for licensed producers (LPs) in regions where cannabis cultivation is restricted or heavily regulated.

Segmentation by Type

CBD type is the leading segment and held around half a share in value in 2022.
The THC will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Application

The anxiety and pain management governs the largest distribution channel in the world, holding a massive share in 2022.
Nausea treatments are expected to grow rapidly over the forecast period.

Segmentation by Region

North America was fuelling the growth of the cannabinoid biosynthesis industry with a nearly two-fifths share in 2022.
Asia Pacific and Europe collectively account for nearly under 55% share in 2022, with Asia-pacific holding over 22% share in the same year.
The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for Cannabinoid Biosynthesis.

The global cannabinoid biosynthesis market is highly competitive, with numerous companies actively engaged in research and development of biosynthesis technologies. These companies are focused on optimizing the production process, enhancing yields, and developing novel strains of microorganisms for efficient cannabinoid synthesis. Furthermore, partnerships and collaborations between biosynthesis companies, pharmaceutical firms, and licensed producers are becoming increasingly prevalent. These alliances facilitate the exchange of expertise, infrastructure, and resources, fostering innovation and accelerating market penetration.

In U.S., the increasing cancer cases across the country is expected to drive the market for cannabinoid biosynthesises over the forecast period. For instance, according to the data published by National Cancer Institute in September 2020, In the year 2020, the total new cancer cases in U.S. accounted for 1,806,590, the disease is expected to claim the lives of 606,520 individuals.

In Germany, the presence of a significant geriatric population in Germany is forecasted to be a key driver for the cannabinoid biosynthesis market in the country. According to data from the Federal Ministry for Family Affairs, Senior Citizens, Women, and Youth of Germany, the percentage of older individuals in the population is expected to continue growing. Projections indicate that by 2050, approximately 38% of the population will be aged 60 and above, creating a substantial demand for cannabinoid-based products and therapies tailored to the needs of this demographic.

Moreover, the global cannabinoid biosynthesis market is witnessing rapid expansion attributed to the rising demand for pharmaceutical-grade cannabinoids, evolving regulatory environments, and the cost-effectiveness of biosynthesis technology. Ongoing research efforts exploring the therapeutic potential of cannabinoids are projected to drive further market growth and development.

Growing Medical Applications of Cannabinoids.

Cannabinoids, the active compounds in cannabis plants, have demonstrated significant therapeutic potential in treating various medical conditions. As the medical community increasingly recognizes the efficacy of cannabinoids, there is a rising demand for reliable and standardized sources of these compounds, thus propelling the global cannabinoid biosynthesis market.

The growing medical applications of cannabinoids is driving the market growth of global cannabinoid biosynthesis market. Extensive research has unveiled the therapeutic benefits of cannabinoids, particularly in addressing chronic pain, epilepsy, multiple sclerosis, and mental health disorders. Cannabidiol (CBD), has shown promise in alleviating seizures in patients with treatment-resistant forms of epilepsy, reducing inflammation, and managing anxiety and depression. Moreover, tetrahydrocannabinol (THC), another prominent cannabinoid, has exhibited potential in managing pain, stimulating appetite, and mitigating chemotherapy-induced nausea and vomiting symptoms. Cannabinoid biosynthesis technology addresses this demand by offering a controlled and scalable method for producing cannabinoids. Through the engineering of microorganisms, cannabinoids can be synthesized in a laboratory setting, ensuring consistent quality, potency, and purity. This reliable and standardized production process is essential for developing cannabinoid-based medications and treatments, fuelling the growth of the global cannabinoid biosynthesis market.

Rising Prevalence of Chronic Diseases

Chronic diseases such as chronic pain, neurodegenerative disorders, inflammatory conditions, and mental health disorders pose significant challenges to patients and healthcare systems. These conditions often result in persistent symptoms, reduced quality of life, and increased healthcare costs. Traditional pharmaceutical interventions may provide partial relief or be associated with adverse effects, prompting the search for alternative therapies. Cannabinoids have shown promise in addressing various chronic diseases, including pain management, inflammation reduction, neuroprotection, and mood regulation.

Furthermore, mental health disorders, including anxiety disorders, depression, and post-traumatic stress disorder (PTSD), contribute significantly to the global burden of chronic diseases. Emerging evidence suggests that cannabinoids, particularly CBD, may have anxiolytic and antidepressant properties, offering potential therapeutic benefits for individuals with these conditions. Such increasing growth in chronic disease is expected to drive the global cannabinoid biosynthesis market. For instance, according to the report by the National Institute of Health report, in January 2023, The population aged above 80 years and high is expected to increase by 137.26%, from 16.935 million in 2020 to 40.181 million in 2050. Among individuals aged 50 and older, the number with at least one chronic disease is estimated to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, those with multimorbidity are expected to increase by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050.

Stringent Government Regulations for Cannabis Use and Application.

Government regulations vary significantly across regions, making it challenging for companies involved in cannabinoid biosynthesis to operate consistently and at scale. Some countries have imposed stringent licensing requirements, limiting the number of licenses granted for cannabis cultivation or cannabinoid production. These restrictions create barriers to entry for new players in the market and restrict the overall supply of cannabinoids for biosynthesis.

Furthermore, regulatory frameworks often dictate the maximum allowable concentration of specific cannabinoids, such as tetrahydrocannabinol (THC), in products. These restrictions aim to control the psychoactive effects associated with THC. However, stringent limits can hinder the development of cannabinoid-based therapies, as certain medical conditions may require higher concentrations of specific cannabinoids to achieve desired therapeutic effects. Such limitations on cannabinoid concentrations can impede the growth and innovation within the cannabinoid biosynthesis market. For instance, in U.S., Under federal law in the United States, the Controlled Substances Act of 1970 (CSA) criminalizes the use and possession of cannabis, making it illegal for any purpose.

Growing Cases of Multiple Sclerosis

Multiple sclerosis (MS) is characterized as a chronic autoimmune disorder impacting the central nervous system, resulting in a range of incapacitating symptoms including muscle weakness, fatigue, pain, and compromised coordination. Cannabinoids, is an active compound that is found in cannabis plants, have demonstrated potential in managing the symptoms of multiple sclerosis. Studies have shown that cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), can help alleviate pain, reduce muscle spasms, improve sleep quality, and enhance overall quality of life for individuals living with MS. These therapeutic benefits of cannabinoids have garnered significant attention and have led to increased interest in cannabinoid-based therapies for MS patients. By leveraging biosynthesis, researchers and pharmaceutical companies can develop tailored cannabinoid-based therapies for MS patients, addressing their specific needs and improving treatment outcomes. As the understanding of cannabinoids and their role in MS treatment advances, the global cannabinoid biosynthesis market is poised for substantial growth in the pursuit of innovative and effective therapies for multiple sclerosis. For instance, according to the data published by National Institute of Health, in November 2020, as of 2020, the global estimated number of individuals with multiple sclerosis (MS) has reached 2.8 million. This figure represents a 30% increase when applying the same methodology used in 2013. The global prevalence of MS in 2020 is 35.9 per 100,000 people, as per estimates, with a confidence interval of 35.87 to 35.95.

Competitive Landscape

Key Players

The global cannabinoid biosynthesis market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

Amyris, Inc.
Willow Bioscience Inc.
Cronos Group
Zymergen Inc.
Constellation Brands, Inc.
Jazz Pharmaceuticals plc
Canopy Growth Corporation
InMed Pharmaceuticals Inc.
Hyasynth Biologicals Inc.
Renew Biopharma, Inc.

These companies focus on product innovation, expanding their distribution channels, mergers, and acquisitions to stay ahead in the market.

The major players in the global cannabinoid biosynthesis market constantly strive to stay ahead by introducing new products and innovations.

In June 2021, Canopy Growth Corporation and The Supreme Cannabis Company, Inc. announced the successful completion of the previously disclosed arrangement. Under this arrangement, Canopy has acquired all of the outstanding common shares of Supreme, known as the “Supreme Shares.”

In June 2022, Cronos Group Inc., a global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA), a leading platform for cell programming, have announced the completion of the third productivity milestone in their partnership to produce eight cultured cannabinoids. This achievement includes reaching the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid believed to potentially reduce the appetite-enhancing effects of THC. Access to rare cannabinoids will strengthen Cronos’ innovation pipeline and commercialization strategy.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

Cannabinoids are primarily derived from the cannabis plant, but their production can also occur through biosynthesis. While the current preference may not be for biosynthesis, this method holds significant potential to revolutionize the manufacturing of cannabinoids in the near future. Furthermore, growing consumption of cannabis products is driving market growth
Market segmented by type, application, and region.
CBD type is the most popular, and holds the largest market share in 2022.
THC type is the primary fastest-growing type over the forecast period.
Anxiety and pain management is the most common application segment.
Nausea treatment holds the largest CAGR over the forecast period.
North America is leading market growth; the market is highly competitive with key players including Amyris, Inc., Willow Bioscience Inc., Cronos Group, Zymergen Inc., Constellation Brands, Inc., Jazz Pharmaceuticals plc, Canopy Growth Corporation, InMed Pharmaceuticals Inc., Hyasynth Biologicals Inc., Renew Biopharma, Inc. and others.

Future Outlook

Positive outlook for the global cannabinoid biosynthesis market with significant growth potential in the Asia Pacific region

Growing medical applications of cannabinoids across the globe is driving the market
Challenges such as, Stringent government regulations for cannabis use and application are restricting the market growth across the globe over the forecast period.

Segmentation

By Types
- CBD
- CBG
- THC
- Others
By Application
- Anxiety and Pain Management
- Nausea Treatment
- Appetite Stimulation
By Region

North America
- The US.
- Canada
- Mexico
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Cannabinoid Biosynthesis Market
2.2. Global Cannabinoid Biosynthesis Market, By Type
2.3. Global Cannabinoid Biosynthesis Market, By Application
2.4. Global Cannabinoid Biosynthesis Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Cannabinoid Biosynthesis Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Application
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Appetite Stimulation

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Cannabinoid Biosynthesis Market, By Type
7.1. Global Cannabinoid Biosynthesis Market Overview, by Type
7.1.1. Global Cannabinoid Biosynthesis Market Revenue Share, By Type, 2022 Vs 2030 (in %)
7.2. CBD
7.2.1. Global Cannabinoid Biosynthesis Market, By Region, 2017-2030 (US$ Bn)
7.3. CBG
7.3.1. Global Cannabinoid Biosynthesis Market, By Region, 2017-2030 (US$ Bn)
7.4. THC
7.4.1. Global Cannabinoid Biosynthesis Market, By Region, 2017-2030 (US$ Bn)
7.5. Others
7.5.1. Global Cannabinoid Biosynthesis Market, By Region, 2017-2030 (US$ Bn)

8. Global Cannabinoid Biosynthesis Market, By Application
8.1. Global Cannabinoid Biosynthesis Market Overview, by Application
8.1.1. Global Cannabinoid Biosynthesis Market, By Application, 2022 vs 2030 (in %)
8.2. Anxiety and Pain Management
8.2.1. Global Cannabinoid Biosynthesis Market, By Region, 2017-2030 (US$ Bn)
8.3. Nausea Treatment
8.3.1. Global Cannabinoid Biosynthesis Market, By Region, 2017-2030 (US$ Bn)
8.4. Appetite Stimulation
8.4.1. Global Cannabinoid Biosynthesis Market, By Region, 2017-2030 (US$ Bn)

9. Global Cannabinoid Biosynthesis Market, By Region
9.1. Global Cannabinoid Biosynthesis Market Overview, by Region
9.1.1. Global Cannabinoid Biosynthesis Market, By Region, 2022 vs 2030 (in%)
9.2. Type
9.2.1. Global Cannabinoid Biosynthesis Market, By Type, 2017-2030 (US$ Bn)
9.3. Application
9.3.1. Global Cannabinoid Biosynthesis Market, By Application, 2017-2030 (US$ Bn)

10. North America Cannabinoid Biosynthesis Market Analysis
10.1. North America Cannabinoid Biosynthesis Market, by Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. North America Cannabinoid Biosynthesis Market, by Application, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. North America Cannabinoid Biosynthesis Market, by Country, 2017-2030 (US$ Bn)
10.3.1. North America Cannabinoid Biosynthesis Market, by Country, 2022 Vs 2030 (in%)
10.3.2. U.S.
10.3.2.1. U.S. Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. U.S. Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
10.3.2.3. U.S. Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
10.3.3. Canada
10.3.3.1. Canada Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. Canada Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
10.3.3.3. Canada Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
10.3.4. Mexico
10.3.4.1. Mexico Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. Mexico Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
10.3.4.3. Mexico Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)

11. Europe Cannabinoid Biosynthesis Market Analysis
11.1. Europe Cannabinoid Biosynthesis Market, by Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Europe Cannabinoid Biosynthesis Market, by Application, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Europe Cannabinoid Biosynthesis Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Europe Cannabinoid Biosynthesis Market, by Country, 2022 Vs 2030 (in%)
11.3.2. Germany
11.3.2.1. Germany Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Germany Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
11.3.2.3. Germany Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
11.3.3. France
11.3.3.1. France Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. France Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
11.3.3.3. France Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
11.3.4. UK
11.3.4.1. UK Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.4.2. UK Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
11.3.4.3. UK Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
11.3.5. Italy
11.3.5.1. Italy Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.5.2. Italy Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
11.3.5.3. Italy Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
11.3.6. Spain
11.3.6.1. Spain Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.6.2. Spain Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
11.3.6.3. Spain Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
11.3.7. Rest of Europe
11.3.7.1. Rest of Europe Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.7.2. Rest of Europe Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
11.3.7.3. Rest of Europe Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)

12. Asia Pacific Cannabinoid Biosynthesis Market Analysis
12.1. Asia Pacific Cannabinoid Biosynthesis Market, by Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Asia Pacific Cannabinoid Biosynthesis Market, by Application, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Asia Pacific Cannabinoid Biosynthesis Market, by Country, 2017-2030 (US$ Bn)
12.3.1. Asia Pacific Cannabinoid Biosynthesis Market, by Country, 2022 Vs 2030 (in%)
12.3.2. China
12.3.2.1. China Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. China Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
12.3.2.3. China Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
12.3.3. Japan
12.3.3.1. Japan Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Japan Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
12.3.3.3. Japan Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
12.3.4. India
12.3.4.1. India Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.4.2. India Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
12.3.4.3. India Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
12.3.5. South Korea
12.3.5.1. South Korea Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.5.2. South Korea Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
12.3.5.3. South Korea Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
12.3.6. South-East Asia
12.3.6.1. South-East Asia Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.6.2. South-East Asia Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
12.3.6.3. South-East Asia Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
12.3.7. Rest of Asia Pacific
12.3.7.1. Rest of Asia Pacific Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.7.2. Rest of Asia Pacific Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
12.3.7.3. Rest of Asia Pacific Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)

13. Latin America Cannabinoid Biosynthesis Market Analysis
13.1. Latin America Cannabinoid Biosynthesis Market, by Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Latin America Cannabinoid Biosynthesis Market, by Application, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Latin America Cannabinoid Biosynthesis Market, by Country, 2017-2030 (US$ Bn)
13.3.1. Latin America Cannabinoid Biosynthesis Market, by Country, 2022 Vs 2030 (in%)
13.3.2. Brazil
13.3.2.1. Brazil Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.2.2. Brazil Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
13.3.2.3. Brazil Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
13.3.3. Argentina
13.3.3.1. Argentina Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.3.2. Argentina Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
13.3.3.3. Argentina Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
13.3.4. Rest of Latin America
13.3.4.1. Rest of Latin America Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.4.2. Rest of Latin America Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
13.3.4.3. Rest of Latin America Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)

14. Middle East and Africa Cannabinoid Biosynthesis Market Analysis
14.1. Middle East and Africa Cannabinoid Biosynthesis Market, by Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Middle East and Africa Cannabinoid Biosynthesis Market, by Application, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Middle East and Africa Cannabinoid Biosynthesis Market, by Country, 2017-2030 (US$ Bn)
14.3.1. Middle East and Africa Cannabinoid Biosynthesis Market, by Country, 2022 Vs 2030 (in%)
14.3.2. GCC Countries
14.3.2.1. GCC Countries Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.2.2. GCC Countries Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
14.3.2.3. GCC Countries Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
14.3.3. South Africa
14.3.3.1. South Africa Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.3.2. South Africa Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
14.3.3.3. South Africa Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)
14.3.4. Rest of Middle East and Africa
14.3.4.1. Rest of Middle East and Africa Cannabinoid Biosynthesis Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.4.2. Rest of Middle East and Africa Cannabinoid Biosynthesis, By Type, 2017-2030 (US$ Bn)
14.3.4.3. Rest of Middle East and Africa Cannabinoid Biosynthesis, By Application, 2017-2030 (US$ Bn)

15. Company Profiles
15.1. Amyris, Inc.
15.1.1. Company Overview
15.1.2. Product /Services Portfolio
15.1.3. Geographical Presence
15.1.4. Financial Summary
15.1.4.1. Market Revenue and Net Profit (2019-2022)
15.1.4.2. Business Segment Revenue Analysis
15.1.4.3. Geographical Revenue Analysis
15.2. Amyris, Inc.
15.3. Willow Bioscience Inc.
15.4. Cronos Group
15.5. Zymergen Inc.
15.6. Constellation Brands, Inc.
15.7. Jazz Pharmaceuticals plc
15.8. Canopy Growth Corporation
15.9. InMed Pharmaceuticals Inc.
15.10. Hyasynth Biologicals Inc.
15.11. Renew Biopharma, Inc.

List of Figures
FIG. 1 Global Cannabinoid Biosynthesis Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Cannabinoid Biosynthesis Market Segmentation
FIG. 4 Global Cannabinoid Biosynthesis Market, by Type, 2022 (US$ Bn)
FIG. 5 Global Cannabinoid Biosynthesis Market, by Application, 2022 (US$ Bn)
FIG. 6 Global Cannabinoid Biosynthesis Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Type, 2022
FIG. 8 Attractive Investment Proposition, by Application, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Cannabinoid Biosynthesis Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Cannabinoid Biosynthesis Market Manufacturers, 2022
FIG. 12 Global Cannabinoid Biosynthesis Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 13 Global Cannabinoid Biosynthesis Market, by CBD, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Cannabinoid Biosynthesis Market, by CBG, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Cannabinoid Biosynthesis Market, by THC, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Cannabinoid Biosynthesis Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Cannabinoid Biosynthesis Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 18 Global Cannabinoid Biosynthesis Market, by Anxiety and Pain Management, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Cannabinoid Biosynthesis Market, by Nausea Treatment, 2017-2030 (US$ Bn)
FIG. 20 Global Cannabinoid Biosynthesis Market, by Appetite Stimulation, 2017-2030 (US$ Bn)
FIG. 21 North America Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 22 U.S. Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 23 Canada Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 24 Europe Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 25 Germany Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 26 France Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 27 U.K. Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 28 Italy Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 29 Spain Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 30 Rest of Europe Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 31 Asia Pacific Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 32 China Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 33 Japan Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 34 India Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 35 South Korea Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 36 South-East Asia Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 37 Rest of Asia Pacific Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 38 Latin America Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 39 Brazil Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 40 Mexico Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 41 Rest of Latin America Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 42 Middle East & Africa Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 43 GCC Countries Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 44 South Africa Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Middle East and Africa Cannabinoid Biosynthesis Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Cannabinoid Biosynthesis Market
TABLE 2 Global Cannabinoid Biosynthesis Market: Market Drivers Impact Analysis
TABLE 3 Global Cannabinoid Biosynthesis Market: Market Restraints Impact Analysis
TABLE 4 Global Cannabinoid Biosynthesis Market, by Competitive Benchmarking, 2022
TABLE 5 Global Cannabinoid Biosynthesis Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Cannabinoid Biosynthesis Market, by Key Strategies Analysis, 2022
TABLE 7 Global Cannabinoid Biosynthesis Market, by CBD, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Cannabinoid Biosynthesis Market, by CBD, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Cannabinoid Biosynthesis Market, by CBG, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Cannabinoid Biosynthesis Market, by CBG, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Cannabinoid Biosynthesis Market, by THC, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Cannabinoid Biosynthesis Market, by THC, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Cannabinoid Biosynthesis Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Cannabinoid Biosynthesis Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Cannabinoid Biosynthesis Market, by Anxiety and Pain Management, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Cannabinoid Biosynthesis Market, by Anxiety and Pain Management, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Cannabinoid Biosynthesis Market, by Nausea Treatment, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Cannabinoid Biosynthesis Market, by Nausea Treatment, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Cannabinoid Biosynthesis Market, by Appetite Stimulation, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Cannabinoid Biosynthesis Market, by Appetite Stimulation, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 22 Global Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 23 Global Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 24 Global Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 25 Global Cannabinoid Biosynthesis Market, by Region, 2017-2022 (US$ Bn)
TABLE 26 Global Cannabinoid Biosynthesis Market, by Region, 2023-2030 (US$ Bn)
TABLE 27 North America Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 28 North America Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 29 North America Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 30 North America Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 31 North America Cannabinoid Biosynthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 32 North America Cannabinoid Biosynthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 33 United States Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 34 United States Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 35 United States Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 36 United States Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 37 Canada Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 38 Canada Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 39 Canada Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 40 Canada Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 41 Mexico Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 42 Mexico Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 43 Mexico Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 44 Mexico Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 45 Europe Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 46 Europe Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 47 Europe Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 48 Europe Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 49 Europe Cannabinoid Biosynthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 50 Europe Cannabinoid Biosynthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 51 Germany Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 52 Germany Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 53 Germany Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 54 Germany Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 55 France Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 56 France Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 57 France Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 58 France Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 59 United Kingdom Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 60 United Kingdom Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 61 United Kingdom Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 62 United Kingdom Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 63 Italy Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 64 Italy Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 65 Italy Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 66 Italy Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 67 Spain Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 68 Spain Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 69 Spain Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 70 Spain Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 71 Rest of Europe Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 72 Rest of Europe Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 73 Rest of Europe Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 74 Rest of Europe Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 75 Asia Pacific Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 76 Asia Pacific Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 77 Asia Pacific Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 78 Asia Pacific Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 79 Asia Pacific Cannabinoid Biosynthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 80 Asia Pacific Cannabinoid Biosynthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 81 China Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 82 China Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 83 China Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 84 China Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 85 Japan Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 86 Japan Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 87 Japan Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 88 Japan Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 89 India Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 90 India Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 91 India Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 92 India Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 93 South Korea Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 94 South Korea Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 95 South Korea Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 96 South Korea Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 97 South-East Asia Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 98 South-East Asia Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 99 South-East Asia Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 100 South-East Asia Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 101 Rest of Asia Pacific Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 102 Rest of Asia Pacific Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 103 Rest of Asia Pacific Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 104 Rest of Asia Pacific Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 105 Latin America Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 106 Latin America Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 107 Latin America Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 108 Latin America Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 109 Latin America Cannabinoid Biosynthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 110 Latin America Cannabinoid Biosynthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 111 Brazil Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 112 Brazil Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 113 Brazil Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 114 Brazil Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 115 Argentina Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 116 Argentina Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 117 Argentina Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 118 Argentina Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 119 Rest of Latin America Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 120 Rest of Latin America Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 121 Rest of Latin America Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 122 Rest of Latin America Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 123 Middle East and Africa Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 124 Middle East and Africa Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 125 Middle East and Africa Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 126 Middle East and Africa Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 127 Middle East and Africa Cannabinoid Biosynthesis Market, by Country, 2017-2022 (US$ Bn)
TABLE 128 Middle East and Africa Cannabinoid Biosynthesis Market, by Country, 2023-2030 (US$ Bn)
TABLE 129 GCC Countries Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 130 GCC Countries Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 131 GCC Countries Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 132 GCC Countries Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 133 South Africa Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 134 South Africa Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 135 South Africa Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 136 South Africa Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)
TABLE 137 Rest of Middle East and Africa Cannabinoid Biosynthesis Market, by Type, 2017-2022 (US$ Bn)
TABLE 138 Rest of Middle East and Africa Cannabinoid Biosynthesis Market, by Type, 2023-2030 (US$ Bn)
TABLE 139 Rest of Middle East and Africa Cannabinoid Biosynthesis Market, by Application, 2017-2022 (US$ Bn)
TABLE 140 Rest of Middle East and Africa Cannabinoid Biosynthesis Market, by Application, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of the global cannabinoid biosynthesis market?

The global cannabinoid biosynthesis market was valued at USD 16.2 Billion in 2022.

What is the expected growth rate of the cannabinoid biosynthesis market between 2023 and 2030?

The cannabinoid biosynthesis market is projected to exhibit a compound annual growth rate (CAGR) of 16.50% from 2023 to 2030, with an estimated value of USD 47.18 billion by 2030.

Which product segment is leading the market share in terms of type?

CBD is the leading segment by type, holding around half of the share in value in 2022.

Which application segment governs the demand for cannabinoid biosynthesis in the world?

The anxiety and pain management segment governs the demand for cannabinoid biosynthesis, holding a massive share in 2022.

Which type segment is expected to post the highest CAGR during the forecast period?

The THC segment is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the cannabinoid biosynthesis industry?

North America is fueling the growth of the cannabinoid biosynthesis industry, with a nearly two-fifth share in 2022.

Who are the major players in the global cannabinoid biosynthesis market?

The top players include Amyris, Inc., Willow Bioscience Inc., Cronos Group, Zymergen Inc., Constellation Brands, Inc., Jazz Pharmaceuticals plc, Canopy Growth Corporation, InMed Pharmaceuticals Inc., Hyasynth Biologicals Inc., Renew Biopharma, Inc. and others

What is the major market driver of the cannabinoid biosynthesis industry?

The growing medical applications of cannabinoids are the major market drivers

What are the major market restraints of the cannabinoid biosynthesis industry?

Stringent government regulations for cannabis use and application restraints of cannabinoid biosynthesis industry.

What are the major market opportunities of the cannabinoid biosynthesis industry?

Growing cases of multiple sclerosis across the globe is expected to create lucrative growth opportunities for the global cannabinoid biosynthesis market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –